SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3ra2'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P6K_A_MTLA870_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 393 ASN A 384 GLN A 388 PHE A 276	None	1.24A	1p6kA-3ra2A: undetectable	1p6kA-3ra2A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P6K_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 393 ASN A 384 GLN A 388 PHE A 276	None	1.24A	1p6kB-3ra2A: undetectable	1p6kB-3ra2A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RS6_A_MTLA870_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 393 ASN A 384 GLN A 388 PHE A 276	None	1.24A	1rs6A-3ra2A: undetectable	1rs6A-3ra2A: 21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RS6_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 393 ASN A 384 GLN A 388 PHE A 276	None	1.26A	1rs6B-3ra2A: undetectable	1rs6B-3ra2A: 21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RS7_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 393 ASN A 384 GLN A 388 PHE A 276	None	1.23A	1rs7B-3ra2A: undetectable	1rs7B-3ra2A: 21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_W_CHDW4060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.87A	1v54N-3ra2A: undetectable 1v54W-3ra2A: undetectable	1v54N-3ra2A: 23.22 1v54W-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_J_CHDJ3060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.94A	1v55A-3ra2A: undetectable 1v55J-3ra2A: undetectable	1v55A-3ra2A: 23.22 1v55J-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Z35_A_2FAA300_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	5 / 10	GLY A 639 THR A 731 VAL A 614 GLU A 565 SER A 634	None	1.20A	1z35A-3ra2A: undetectable	1z35A-3ra2A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZQ_A_MTLA870_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 393 ASN A 384 GLN A 388 PHE A 276	None	1.23A	1zzqA-3ra2A: undetectable	1zzqA-3ra2A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZQ_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 393 ASN A 384 GLN A 388 PHE A 276	None	1.24A	1zzqB-3ra2A: undetectable	1zzqB-3ra2A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_A_MTLA870_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 393 ASN A 384 GLN A 388 PHE A 276	None	1.22A	1zzuA-3ra2A: undetectable	1zzuA-3ra2A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 393 ASN A 384 GLN A 388 PHE A 276	None	1.24A	1zzuB-3ra2A: undetectable	1zzuB-3ra2A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.85A	2dyrN-3ra2A: undetectable 2dyrW-3ra2A: undetectable	2dyrN-3ra2A: 23.22 2dyrW-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VQY_A_PARA1201_2 (AAC(6')-IB)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	3 / 3	TRP A 282 GLN A 648 TRP A 248	None	1.36A	2vqyA-3ra2A: undetectable	2vqyA-3ra2A: 16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7H_B_SAMB530_1 (TYPE I RESTRICTION ENZYME ECOKI M PROTEIN)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	3 / 3	TYR A 733 GLU A 567 THR A 563	None	1.04A	2y7hB-3ra2A: undetectable	2y7hB-3ra2A: 22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.93A	3ablN-3ra2A: undetectable 3ablW-3ra2A: undetectable	3ablN-3ra2A: 23.22 3ablW-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.90A	3ag3A-3ra2A: undetectable 3ag3J-3ra2A: undetectable	3ag3A-3ra2A: 23.22 3ag3J-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_W_CHDW1059_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.89A	3asnN-3ra2A: undetectable 3asnW-3ra2A: undetectable	3asnN-3ra2A: 23.22 3asnW-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N62_B_MTLB870_0 (NITRIC OXIDE SYNTHASE)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 393 ASN A 384 GLN A 388 PHE A 276	None	1.27A	3n62B-3ra2A: undetectable	3n62B-3ra2A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WRK_D_CAMD502_0 (CAMPHOR 5-MONOOXYGENASE)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 5	PHE A 294 LEU A 689 GLY A 308 VAL A 614	None	1.06A	3wrkD-3ra2A: undetectable	3wrkD-3ra2A: 21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E7B_C_ACTC513_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	3 / 3	TYR A 427 HIS A 429 ARG A 736	None	1.07A	4e7bC-3ra2A: undetectable	4e7bC-3ra2A: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F3T_A_IPHA902_0 (PROTEIN ARGONAUTE-2)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 6	LEU A 353 TYR A 355 LEU A 650 TYR A 378	None	1.15A	4f3tA-3ra2A: undetectable	4f3tA-3ra2A: 18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M2V_A_BZ1A302_1 (CARBONIC ANHYDRASE 2)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	5 / 12	LEU A 357 GLN A 648 VAL A 356 GLY A 363 THR A 280	None	0.94A	4m2vA-3ra2A: undetectable	4m2vA-3ra2A: 20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_H_377H401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 6	TYR A 258 ASN A 254 GLU A 399 TYR A 380	None	1.43A	4twdG-3ra2A: undetectable 4twdH-3ra2A: undetectable	4twdG-3ra2A: 22.15 4twdH-3ra2A: 22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U3E_A_ACTA705_0 (RIBONUCLEOSIDE TRIPHOSPHATE REDUCTASE)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 4	HIS A 361 ASP A 286 TYR A 284 VAL A 356	None	1.42A	4u3eA-3ra2A: 0.0	4u3eA-3ra2A: 22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Y_A_EF2A151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.36A	4v2yA-3ra2A: undetectable	4v2yA-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Y_B_EF2B151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.37A	4v2yB-3ra2A: undetectable	4v2yB-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Z_A_Y70A151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.39A	4v2zA-3ra2A: undetectable	4v2zA-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Z_B_Y70B151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.34A	4v2zB-3ra2A: undetectable	4v2zB-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V30_A_LVYA151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.38A	4v30A-3ra2A: undetectable	4v30A-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V30_B_LVYB151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.26A	4v30B-3ra2A: undetectable	4v30B-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4G_A_IPHA903_0 (PROTEIN ARGONAUTE-2)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 6	LEU A 353 TYR A 355 PRO A 354 TYR A 378	None	1.31A	4z4gA-3ra2A: undetectable	4z4gA-3ra2A: 18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A5Z_C_WJZC304_0 (BETA-LACTAMASE NDM-1)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	HIS A 230 LYS A 317 GLY A 227 ASN A 228	None	1.29A	5a5zC-3ra2A: undetectable	5a5zC-3ra2A: 16.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMH_A_EF2A151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.44A	5amhA-3ra2A: undetectable	5amhA-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMI_A_EF2A151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.37A	5amiA-3ra2A: undetectable	5amiA-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMI_B_EF2B151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.39A	5amiB-3ra2A: undetectable	5amiB-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMJ_A_EF2A151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.38A	5amjA-3ra2A: undetectable	5amjA-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMJ_B_EF2B151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.35A	5amjB-3ra2A: undetectable	5amjB-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMK_B_EF2B151_1 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.32A	5amkB-3ra2A: undetectable	5amkB-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTF_G_GFNG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	SER A 426 ASP A 238 ARG A 239 GLU A 686	None	1.09A	5btfA-3ra2A: undetectable 5btfC-3ra2A: undetectable 5btfD-3ra2A: undetectable	5btfA-3ra2A: 20.95 5btfC-3ra2A: 20.95 5btfD-3ra2A: 17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_A_EF2A202_0 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.38A	5oh1A-3ra2A: undetectable	5oh1A-3ra2A: 10.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_B_EF2B202_0 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.33A	5oh1B-3ra2A: undetectable	5oh1B-3ra2A: 10.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH3_A_9V2A202_0 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.38A	5oh3A-3ra2A: undetectable	5oh3A-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH3_B_9V2B202_0 (CEREBLON ISOFORM 4)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 311 PHE A 640 TRP A 621 TYR A 355	None	1.36A	5oh3B-3ra2A: undetectable	5oh3B-3ra2A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.78A	5xdqN-3ra2A: undetectable 5xdqW-3ra2A: undetectable	5xdqN-3ra2A: 23.22 5xdqW-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.92A	5xdxA-3ra2A: undetectable 5xdxJ-3ra2A: undetectable	5xdxA-3ra2A: 23.22 5xdxJ-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.77A	5xdxN-3ra2A: undetectable 5xdxW-3ra2A: undetectable	5xdxN-3ra2A: 23.22 5xdxW-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NJ9_K_SAMK500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	5 / 12	GLY A 618 GLY A 639 ALA A 622 PHE A 418 PHE A 309	None	0.98A	6nj9K-3ra2A: undetectable	6nj9K-3ra2A: 21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMF_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.90A	6nmfA-3ra2A: undetectable 6nmfJ-3ra2A: undetectable	6nmfA-3ra2A: 23.22 6nmfJ-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.95A	6nmpA-3ra2A: undetectable 6nmpJ-3ra2A: undetectable	6nmpA-3ra2A: 23.22 6nmpJ-3ra2A: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3ra2	CAPSID PROTEIN (Adeno-associated dependoparvoviru s A)	4 / 5	ILE A 375 LEU A 250 ARG A 246 LEU A 318	None	0.85A	6nmpN-3ra2A: undetectable 6nmpW-3ra2A: undetectable	6nmpN-3ra2A: 23.22 6nmpW-3ra2A: 9.24

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1P6K_A_MTLA870_0","NITRIC-OXIDE SYNTHASE, BRAIN","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 393;ASN A 384;GLN A 388;PHE A 276","None","1.24A","1p6kA-3ra2A:undetectable","1p6kA-3ra2A:22.69"],["1P6K_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 393;ASN A 384;GLN A 388;PHE A 276","None","1.24A","1p6kB-3ra2A:undetectable","1p6kB-3ra2A:22.69"],["1RS6_A_MTLA870_0","NITRIC-OXIDE SYNTHASE, BRAIN","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 393;ASN A 384;GLN A 388;PHE A 276","None","1.24A","1rs6A-3ra2A:undetectable","1rs6A-3ra2A:21.93"],["1RS6_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 393;ASN A 384;GLN A 388;PHE A 276","None","1.26A","1rs6B-3ra2A:undetectable","1rs6B-3ra2A:21.93"],["1RS7_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 393;ASN A 384;GLN A 388;PHE A 276","None","1.23A","1rs7B-3ra2A:undetectable","1rs7B-3ra2A:21.93"],["1V54_W_CHDW4060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.87A","1v54N-3ra2A:undetectable;1v54W-3ra2A:undetectable","1v54N-3ra2A:23.22;1v54W-3ra2A:9.24"],["1V55_J_CHDJ3060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.94A","1v55A-3ra2A:undetectable;1v55J-3ra2A:undetectable","1v55A-3ra2A:23.22;1v55J-3ra2A:9.24"],["1Z35_A_2FAA300_1","PURINE NUCLEOSIDE PHOSPHORYLASE","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",5,"GLY A 639;THR A 731;VAL A 614;GLU A 565;SER A 634","None","1.20A","1z35A-3ra2A:undetectable","1z35A-3ra2A:20.21"],["1ZZQ_A_MTLA870_0","NITRIC-OXIDE SYNTHASE, BRAIN","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 393;ASN A 384;GLN A 388;PHE A 276","None","1.23A","1zzqA-3ra2A:undetectable","1zzqA-3ra2A:22.65"],["1ZZQ_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 393;ASN A 384;GLN A 388;PHE A 276","None","1.24A","1zzqB-3ra2A:undetectable","1zzqB-3ra2A:22.65"],["1ZZU_A_MTLA870_0","NITRIC-OXIDE SYNTHASE, BRAIN","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 393;ASN A 384;GLN A 388;PHE A 276","None","1.22A","1zzuA-3ra2A:undetectable","1zzuA-3ra2A:22.65"],["1ZZU_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 393;ASN A 384;GLN A 388;PHE A 276","None","1.24A","1zzuB-3ra2A:undetectable","1zzuB-3ra2A:22.65"],["2DYR_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.85A","2dyrN-3ra2A:undetectable;2dyrW-3ra2A:undetectable","2dyrN-3ra2A:23.22;2dyrW-3ra2A:9.24"],["2VQY_A_PARA1201_2","AAC(6')-IB","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",3,"TRP A 282;GLN A 648;TRP A 248","None","1.36A","2vqyA-3ra2A:undetectable","2vqyA-3ra2A:16.70"],["2Y7H_B_SAMB530_1","TYPE I RESTRICTION ENZYME ECOKI M PROTEIN","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",3,"TYR A 733;GLU A 567;THR A 563","None","1.04A","2y7hB-3ra2A:undetectable","2y7hB-3ra2A:22.88"],["3ABL_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.93A","3ablN-3ra2A:undetectable;3ablW-3ra2A:undetectable","3ablN-3ra2A:23.22;3ablW-3ra2A:9.24"],["3AG3_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.90A","3ag3A-3ra2A:undetectable;3ag3J-3ra2A:undetectable","3ag3A-3ra2A:23.22;3ag3J-3ra2A:9.24"],["3ASN_W_CHDW1059_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.89A","3asnN-3ra2A:undetectable;3asnW-3ra2A:undetectable","3asnN-3ra2A:23.22;3asnW-3ra2A:9.24"],["3N62_B_MTLB870_0","NITRIC OXIDE SYNTHASE","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 393;ASN A 384;GLN A 388;PHE A 276","None","1.27A","3n62B-3ra2A:undetectable","3n62B-3ra2A:22.65"],["3WRK_D_CAMD502_0","CAMPHOR 5-MONOOXYGENASE","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PHE A 294;LEU A 689;GLY A 308;VAL A 614","None","1.06A","3wrkD-3ra2A:undetectable","3wrkD-3ra2A:21.94"],["4E7B_C_ACTC513_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",3,"TYR A 427;HIS A 429;ARG A 736","None","1.07A","4e7bC-3ra2A:undetectable","4e7bC-3ra2A:20.64"],["4F3T_A_IPHA902_0","PROTEIN ARGONAUTE-2","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"LEU A 353;TYR A 355;LEU A 650;TYR A 378","None","1.15A","4f3tA-3ra2A:undetectable","4f3tA-3ra2A:18.41"],["4M2V_A_BZ1A302_1","CARBONIC ANHYDRASE 2","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",5,"LEU A 357;GLN A 648;VAL A 356;GLY A 363;THR A 280","None","0.94A","4m2vA-3ra2A:undetectable","4m2vA-3ra2A:20.57"],["4TWD_H_377H401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"TYR A 258;ASN A 254;GLU A 399;TYR A 380","None","1.43A","4twdG-3ra2A:undetectable;4twdH-3ra2A:undetectable","4twdG-3ra2A:22.15;4twdH-3ra2A:22.15"],["4U3E_A_ACTA705_0","RIBONUCLEOSIDE TRIPHOSPHATE REDUCTASE","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"HIS A 361;ASP A 286;TYR A 284;VAL A 356","None","1.42A","4u3eA-3ra2A:0.0","4u3eA-3ra2A:22.40"],["4V2Y_A_EF2A151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.36A","4v2yA-3ra2A:undetectable","4v2yA-3ra2A:13.86"],["4V2Y_B_EF2B151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.37A","4v2yB-3ra2A:undetectable","4v2yB-3ra2A:13.86"],["4V2Z_A_Y70A151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.39A","4v2zA-3ra2A:undetectable","4v2zA-3ra2A:13.86"],["4V2Z_B_Y70B151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.34A","4v2zB-3ra2A:undetectable","4v2zB-3ra2A:13.86"],["4V30_A_LVYA151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.38A","4v30A-3ra2A:undetectable","4v30A-3ra2A:13.86"],["4V30_B_LVYB151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.26A","4v30B-3ra2A:undetectable","4v30B-3ra2A:13.86"],["4Z4G_A_IPHA903_0","PROTEIN ARGONAUTE-2","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"LEU A 353;TYR A 355;PRO A 354;TYR A 378","None","1.31A","4z4gA-3ra2A:undetectable","4z4gA-3ra2A:18.21"],["5A5Z_C_WJZC304_0","BETA-LACTAMASE NDM-1","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"HIS A 230;LYS A 317;GLY A 227;ASN A 228","None","1.29A","5a5zC-3ra2A:undetectable","5a5zC-3ra2A:16.95"],["5AMH_A_EF2A151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.44A","5amhA-3ra2A:undetectable","5amhA-3ra2A:13.86"],["5AMI_A_EF2A151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.37A","5amiA-3ra2A:undetectable","5amiA-3ra2A:13.86"],["5AMI_B_EF2B151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.39A","5amiB-3ra2A:undetectable","5amiB-3ra2A:13.86"],["5AMJ_A_EF2A151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.38A","5amjA-3ra2A:undetectable","5amjA-3ra2A:13.86"],["5AMJ_B_EF2B151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.35A","5amjB-3ra2A:undetectable","5amjB-3ra2A:13.86"],["5AMK_B_EF2B151_1","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.32A","5amkB-3ra2A:undetectable","5amkB-3ra2A:13.86"],["5BTF_G_GFNG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"SER A 426;ASP A 238;ARG A 239;GLU A 686","None","1.09A","5btfA-3ra2A:undetectable;5btfC-3ra2A:undetectable;5btfD-3ra2A:undetectable","5btfA-3ra2A:20.95;5btfC-3ra2A:20.95;5btfD-3ra2A:17.55"],["5OH1_A_EF2A202_0","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.38A","5oh1A-3ra2A:undetectable","5oh1A-3ra2A:10.48"],["5OH1_B_EF2B202_0","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.33A","5oh1B-3ra2A:undetectable","5oh1B-3ra2A:10.48"],["5OH3_A_9V2A202_0","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.38A","5oh3A-3ra2A:undetectable","5oh3A-3ra2A:13.86"],["5OH3_B_9V2B202_0","CEREBLON ISOFORM 4","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"PRO A 311;PHE A 640;TRP A 621;TYR A 355","None","1.36A","5oh3B-3ra2A:undetectable","5oh3B-3ra2A:13.86"],["5XDQ_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.78A","5xdqN-3ra2A:undetectable;5xdqW-3ra2A:undetectable","5xdqN-3ra2A:23.22;5xdqW-3ra2A:9.24"],["5XDX_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.92A","5xdxA-3ra2A:undetectable;5xdxJ-3ra2A:undetectable","5xdxA-3ra2A:23.22;5xdxJ-3ra2A:9.24"],["5XDX_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.77A","5xdxN-3ra2A:undetectable;5xdxW-3ra2A:undetectable","5xdxN-3ra2A:23.22;5xdxW-3ra2A:9.24"],["6NJ9_K_SAMK500_0","HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",5,"GLY A 618;GLY A 639;ALA A 622;PHE A 418;PHE A 309","None","0.98A","6nj9K-3ra2A:undetectable","6nj9K-3ra2A:21.20"],["6NMF_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.90A","6nmfA-3ra2A:undetectable;6nmfJ-3ra2A:undetectable","6nmfA-3ra2A:23.22;6nmfJ-3ra2A:9.24"],["6NMP_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.95A","6nmpA-3ra2A:undetectable;6nmpJ-3ra2A:undetectable","6nmpA-3ra2A:23.22;6nmpJ-3ra2A:9.24"],["6NMP_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3ra2","CAPSID PROTEIN","Adeno-associated dependoparvovirus A",4,"ILE A 375;LEU A 250;ARG A 246;LEU A 318","None","0.85A","6nmpN-3ra2A:undetectable;6nmpW-3ra2A:undetectable","6nmpN-3ra2A:23.22;6nmpW-3ra2A:9.24"]]